Greater Than Minimal Risk, No Direct Benefit – Bridging Drug Trials and Novel Therapy in Pediatric Populations

Gelijkaardige items

• Clearing Muddy Waters: The Need to Reconceptualize Minor Increase over Minimal Risk in Pediatric Rare Disease Research
  door: Duenas, Devan M., et al.
  Gepubliceerd in: (2020)
• Conflicts of Interest and Recommendations for Clinical Treatments That Benefit Researchers
  door: Wilfond, Benjamin S., et al.
  Gepubliceerd in: (2020)
• Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?
  door: Johnson, Liza-Marie, et al.
  Gepubliceerd in: (2020)
• Click Here to Complete This Survey: Online Research, Adolescents, and Parental Consent
  door: Johnson, Liza-Marie, et al.
  Gepubliceerd in: (2020)
• Minimally Invasive Hysterectomy for Uteri Greater Than One Kilogram
  door: Ito, Traci E., et al.
  Gepubliceerd in: (2017)